Amplification of MDM2 has been detected in multiple tumours including sarcomas [167], lung cancer [168] and colorectal cancer [169], moreover, MDM2 over-expression is also linked to poor prognosis and increased chemotherapeutic resistance [170]. The gene discussed is MDM2; the disease is sarcoma.